NCT05251181 - A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent | Biotech Hunter

Enrollment

430

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions

Hypovolemic Shock

Interventions

DRUG

Normal Saline

Normal Saline to be Used as Vehicle in the Phase-III Study to Assess Efficacy of Centhaquine as a Resuscitative Agent for Hypovolemic Shock

DRUG

Centhaquine

Phase-III Study to Assess Efficacy of Centhaquine as a Resuscitative Agent for Hypovolemic Shock